| Financial Year |
March 31 2023 |
| Monetary Funds |
398,723,374.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,760,484.00 |
| Accounts Receivable |
546,103,530.59 |
| Advances to Suppliers |
130,796,019.43 |
| Other Receivables |
21,870,374.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
159,655,863.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,990,875.21 |
| Other Current Assets |
28,751,383.60 |
| Total Current Assets |
1,293,651,905.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,505,642.88 |
| Long-term Equity Investment |
1,228,896.09 |
| Investment Properties |
13,943,141.35 |
| Fixed Assetes |
14,211,728.14 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,948,695.46 |
| R&D expenses |
-- |
| Goodwill |
170,665,911.45 |
| Long-Term Deferred and Prepaid Expenses |
5,949,639.05 |
| Deferred Income Tax Assets |
8,943,619.67 |
| Other Non-Current Assets |
2,188,312.90 |
| Sub-Total of Non-Current Assets |
300,793,438.33 |
| Total Assets |
1,594,445,343.64 |
| Short-Term Loans |
234,986,763.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
108,582,298.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
63,258,502.24 |
| Taxes Payable |
61,110,550.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,183,356.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,834,871.30 |
| Other Current Liabilities |
4,062,877.14 |
| Sub-Total of Current Liabilities |
538,489,600.91 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,570,957.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,346,109.98 |
| Total Liabilities |
561,835,710.89 |
| Paid-In Capital(Or Share Stock) |
223,170,841.00 |
| Capital Surplus |
250,055,384.01 |
| Surplus Reserve |
92,514,948.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
442,389,800.30 |
| Minority Stockholder's Interest |
21,283,369.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,011,326,262.82 |
| Owner's Equity（Stockholder's Equity） |
1,032,609,632.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,594,445,343.64 |
